JW Pharmaceutical Corporation (001067.KS) KSC

45,600.00

-3200(-6.56%)

Updated at June 02 03:30PM

Currency In KRW

Valuation

Market Cap615.62B
Enterprise Value631.02B
P/E Ratio8.61
PEG Ratio0.53
Price/Sales Ratio0.79
Price/Book Ratio1.61
Enterprise/Revenue0.83
Enterprise/EBITDA5.6

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.09
Operating Margin0.13

Management Effectiveness

Return On Assets0.12
Return On Equity0.2

Income Statement

Revenue774.8B
Revenue/Share34,493.35
Gross Profit359.31B
EBITDA106.62B
Net Income61.69B
Diluted EPS2,534.75

Balance Sheet

Total Cash31.69B
Total Cash/Share1,384.41
Total Debt54.12B
Total Debt/Equity0.14
Current Ratio1.46
Book Value Per Share16,681.05

Price History

52-Week Change-28.41
52-Week High65,600
52-Week Low45,600
Moving Average 50 Days54,392
Moving Average 200 Days58,369

Statistics

Average Volume59
Shares Outstanding9.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate650
Trailing Annual Dividend Yield2.42
Payout Ratio0.15
Last Split Factor51:50
Last Split DateDecember 27, 2023